Elevated Concentrations of Neurofilament Light Chain in the Cerebrospinal Fluid of Bipolar Disorder Patients

Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls

(2013) Erik Pålsson et al.   BMC Psychiatry

Serum S100B Represents a New Biomarker for Mood Disorders

(2013) Matthias Schroeter et al.   CURRENT DRUG TARGETS

The societal cost of bipolar disorder in Sweden

(2013) Mattias Ekman et al.   SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY

The association between cognitive function and white matter lesion location in older adults: a systematic review

(2012) Niousha Bolandzadeh et al.   BMC Neurology

Treatment-emergent adverse events associated with atypical antipsychotics

(2012) Danielle S Cha et al.   EXPERT OPINION ON PHARMACOTHERAPY

Altered Concentrations of Amyloid Precursor Protein Metabolites in the Cerebrospinal Fluid of Patients with Bipolar Disorder

(2012) Joel Jakobsson et al.   NEUROPSYCHOPHARMACOLOGY

Plasma Neurofilament Heavy Chain Levels Correlate to Markers of Late Stage Disease Progression and Treatment Response in SOD1G93A Mice that Model ALS

(2012) Ching-Hua Lu et al.   PLoS One

Prevalence and Correlates of Bipolar Spectrum Disorder in the World Mental Health Survey Initiative

(2011) Kathleen R. Merikangas et al.   ARCHIVES OF GENERAL PSYCHIATRY

Long-term Antipsychotic Treatment and Brain Volumes

(2011) Beng-Choon Ho et al.   ARCHIVES OF GENERAL PSYCHIATRY

Translating biomarkers to clinical practice

(2011) R H Perlis   MOLECULAR PSYCHIATRY

Biomarker-based dissection of neurodegenerative diseases

(2011) Bob Olsson et al.   PROGRESS IN NEUROBIOLOGY

Manic episodes are associated with grey matter volume reduction - a voxel-based morphometry brain analysis

(2010) C. J. Ekman et al.   ACTA PSYCHIATRICA SCANDINAVICA

Axonal damage in relapsing multiple sclerosis is markedly reduced by natalizumab

(2010) Martin Gunnarsson et al.   ANNALS OF NEUROLOGY

Volumetric neuroimaging investigations in mood disorders: bipolar disorder versus major depressive disorder

(2010) Jakub Z Konarski et al.   BIPOLAR DISORDERS

Lamotrigine for neuroprotection in secondary progressive multiple sclerosis: a randomised, double-blind, placebo-controlled, parallel-group trial

(2010) Raju Kapoor et al.   LANCET NEUROLOGY

Neurofilament light as a prognostic marker in multiple sclerosis

(2010) Jonatan Salzer et al.   Multiple Sclerosis Journal

A history of childhood attention-deficit hyperactivity disorder (ADHD) impacts clinical outcome in adult bipolar patients regardless of current ADHD

(2009) E. Rydén et al.   ACTA PSYCHIATRICA SCANDINAVICA

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009

(2009) Lakshmi N Yatham et al.   BIPOLAR DISORDERS

Subcortical Vascular Dementia Biomarker Pattern in Mild Cognitive Impairment

(2009) Maria Bjerke et al.   DEMENTIA AND GERIATRIC COGNITIVE DISORDERS

Neurocognitive Dysfunctions in Euthymic Bipolar Patients With and Without Prior History of Alcohol Use

(2009) Jose Sanchez-Moreno et al.   JOURNAL OF CLINICAL PSYCHIATRY

Meta-analysis, Database, and Meta-regression of 98 Structural Imaging Studies in Bipolar Disorder

(2008) Matthew J. Kempton et al.   ARCHIVES OF GENERAL PSYCHIATRY

Serum markers support disease-specific glial pathology in major depression

(2008) Matthias L. Schroeter et al.   JOURNAL OF AFFECTIVE DISORDERS

Review of the Multiple Aspects of Neurofilament Functions, and their Possible Contribution to Neurodegeneration

(2008) Rodolphe Perrot et al.   MOLECULAR NEUROBIOLOGY